Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|December 6, 2018
Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancerViswanath Gunda, Benjamin Gigliotti, Tameem Ashry, et al.
Frontiers in Immunology|August 7, 2023
Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 miceZhen Xu, Hyo Shik Shin, Yoo Hyung Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|November 9, 2016
Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid CarcinomaCarrie C Lubitz, Lucia De Gregorio, Abbey L Fingeret, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 23, 2024
Sustained and Localized Drug Depot Release Using Radiation-Activated Scintillating NanoparticlesMikyung Kang, Jeremy Quintana, Huiyu Hu, et al.
Surgery|November 20, 2012
BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrenceJason D Prescott, Peter M Sadow, Richard A Hodin, et al.
Nature Communications|March 7, 2024
Epigenetic profiling reveals key genes and cis-regulatory networks specific to human parathyroidsYoungsook Lucy Jung, Wenping Zhao, Ian Li, et al.
The Oncologist|March 1, 2011
Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancerCarmelo Nucera, Matthew A Nehs, Sushruta S Nagarkatti, et al.
Surgery|December 8, 2010
Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidismCarrie C Lubitz, George J Hunter, Leena M Hamberg, et al.
The American Journal of Cardiology|February 8, 2006
Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitusSheena S Mehta, Robert J Silver, Arthur Aaronson, et al.
Thyroid : Official Journal of the American Thyroid Association|January 31, 2018
Circulating BRAFV600E Levels Correlate with Treatment in Patients with Thyroid CarcinomaCarrie C Lubitz, Tiannan Zhan, Viswanath Gunda, et al.
Pageof 12